ANITA SABICHI to Carcinoma, Transitional Cell
This is a "connection" page, showing publications ANITA SABICHI has written about Carcinoma, Transitional Cell.
Connection Strength
0.974
-
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9.
Score: 0.257
-
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Oncol Rep. 2006 Feb; 15(2):471-7.
Score: 0.225
-
Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells. Clin Cancer Res. 2011 May 01; 17(9):2863-73.
Score: 0.080
-
Identification of genes correlated with early-stage bladder cancer progression. Cancer Prev Res (Phila). 2010 Jun; 3(6):776-86.
Score: 0.076
-
The use of short tandem repeat profiling to characterize human bladder cancer cell lines. J Urol. 2009 Jun; 181(6):2737-48.
Score: 0.070
-
Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. Mol Carcinog. 2008 Sep; 47(9):678-85.
Score: 0.067
-
Comparative outcomes of bladder cancer. Obstet Gynecol. 2006 Jul; 108(1):169-75.
Score: 0.058
-
Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Res. 2005 Mar 01; 65(5):1808-13.
Score: 0.053
-
Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder. Urol Oncol. 2003 Jul-Aug; 21(4):266-70.
Score: 0.047
-
Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):391-5.
Score: 0.040